Seven Editora
##common.pageHeaderLogo.altText##
##common.pageHeaderLogo.altText##

Contact

  • Seven Publicações Ltda CNPJ: 43.789.355/0001-14 Rua: Travessa Aristides Moleta, 290- São José dos Pinhais/PR CEP: 83045-090
  • Principal Contact
  • Nathan Albano Valente
  • (41) 9 8836-2677
  • editora@sevenevents.com.br
  • Support Contact
  • contato@sevenevents.com.br

Cannabis and its dilemmas in psychiatry

  • 08/05/2023
  • 08/05/2023
Facco VB;
Rodrigues FG;
Castel GMD;
Campos LF;
Cas ME;
Dariz PHS;
Escobar JJR

Vinicius Broilo Facco

Fernando Gabriel Rodrigues

Giulia Maria Dal Castel

Larissa Ferreira Campos

Martina Estacia da Cas

Pedro Henrique Sarmento Dariz

Jefferson José Rodrigues Escobar

Keywords

Cannabinoids
Cannabis
Psychiatry

Abstract

In the 1960s, the two main chemical structures in the Cannabis plant were isolated: delta-9-tetrahydrocannabinol (Δ9 -THC), a psychotropic component of the plant, and cannabidiol (CBD), a non-psychotropic substance with therapeutic potential. The possible use as a medicine is justified by the wide distribution of cannabinoid receptors in the body. There is still no consensus on the use of CBD in the treatment of psychiatric conditions, as the implementation of this new therapy has been controversial. The Brazilian Association of Psychiatry (ABP) was irremediably against its use, despite some studies reporting benefits.

 

DOI:https://doi.org/10.56238/alookdevelopv1-022

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2023 Vinicius Broilo Facco, Fernando Gabriel Rodrigues, Giulia Maria Dal Castel, Larissa Ferreira Campos, Martina Estacia da Cas, Pedro Henrique Sarmento Dariz, Jefferson José Rodrigues Escobar
Chapter 22

Author(s)

  • Vinicius Broilo Facco
  • Fernando Gabriel Rodrigues
  • Giulia Maria Dal Castel
  • Larissa Ferreira Campos
  • Martina Estacia da Cas
  • Pedro Henrique Sarmento Dariz
  • Jefferson José Rodrigues Escobar